Legend Biotech Corporation
NASDAQ:LEGN · NASDAQ Global Select
-$4.53 today
Vol 13.60M · Avg 2.42M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-17.49%
Period High
$44.32
Period Low
$16.65
Latest
$27.93
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Scholar Rock Holding Corporation
NASDAQ:SRRK
$5.75B
CG Oncology, Inc. Common stock
NASDAQ:CGON
$5.49B
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
$4.27B
Celcuity Inc.
NASDAQ:CELC
$4.26B
IDEAYA Biosciences, Inc.
NASDAQ:IDYA
$3.04B
Adaptive Biotechnologies Corporation
NASDAQ:ADPT
$2.79B
Disc Medicine, Inc.
NASDAQ:IRON
$2.75B
Tarsus Pharmaceuticals, Inc.
NASDAQ:TARS
$2.73B
Zai Lab Limited
NASDAQ:ZLAB
$2.12B
Ascentage Pharma Group International
NASDAQ:AAPG
$402.07M
What is the latest LEGN filing?
The latest filing shown is F-6EF dated Jun 17, 2026.
How many recent filings does LEGN have?
Intrinsic Alpha currently shows 20 recent filings for LEGN.
Explore More
Continue the stock analysis
Jump to another research area for this company.